Post-marketing Surveillance (PMS) Study to Observe the Safety and Effectiveness of ARNUITY in Asthma Subjects in a Real World Setting
NCT03595930
·
clinicaltrials.gov ↗
COMPLETED
Status
668
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Arnuity
Sponsor
GlaxoSmithKline